Literature DB >> 4016099

Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors.

T Tanaka, Y Minematsu, C F Reilly, J Travis, J C Powers.   

Abstract

The extended substrate binding site of cathepsin G from human leukocytes has been mapped by using a series of peptide 4-nitroanilide substrates. The enzyme has a significant preference for substrates with a P1 Phe over those with the other aromatic amino acids Tyr and Trp. The S2 subsite was mapped with the substrates Suc-Phe-AA-Phe-NA where AA was 13 of the 20 amino acid residues commonly found in proteins. The best residues were Pro and Met. The S3 subsite was mapped with the sequence Suc-AA-Pro-Phe-NA by using 14 different amino acid residues for AA. The two best residues were the isosteric Val and Thr. No significant improvement in reactivity was obtained by extending the substrate to include seven different P4 residues. The kinetic parameters for cathepsin G are significantly slower than those for many other serine proteases. Changes in the reaction conditions and addition of possible cofactors or ligands were in general found to have little effect on the enzymatic activity, while chemical modifications and proteolysis destroyed the activity of cathepsin G. Cathepsin G hydrolyzed peptides containing model desmosine residues and prefers the hydrophobic picolinoyllysine derivative over lysine by substantial margins at both the S4 and S2 subsites but will not tolerate it at S3. Substrates with sequences related to the cathepsin G cleavage site in angiotensin I and angiotensinogen, and the reactive site of alpha 1-antichymotrypsin, were hydrolyzed effectively by enzyme, but with unexceptional rates. Our results indicate that the natural substrate(s) and function(s) of cathepsin G still remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016099     DOI: 10.1021/bi00329a036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.

Authors:  J Plescia; D C Altieri
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.

Authors:  P Hof; I Mayr; R Huber; E Korzus; J Potempa; J Travis; J C Powers; W Bode
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

4.  Sequence variant of the human cathepsin G gene.

Authors:  B Lüdecke; W Poller; K Olek; K Bartholomé
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

5.  Cathepsin G degrades denatured collagen.

Authors:  C Capodici; R A Berg
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

Review 6.  Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition.

Authors:  Stephanie C Ray; Chad A Rappleye
Journal:  Semin Cell Dev Biol       Date:  2018-03-21       Impact factor: 7.727

7.  Role of the chymotrypsin-like membrane-associated proteinase from Treponema denticola ATCC 35405 in inactivation of bioactive peptides.

Authors:  P L Mäkinen; K K Mäkinen; S A Syed
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity.

Authors:  Wilfred W Raymond; Sharon Su; Anastasia Makarova; Todd M Wilson; Melody C Carter; Dean D Metcalfe; George H Caughey
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

9.  An engineered chymotrypsin/cathepsin G site in domain I renders Bacillus thuringiensis Cry3A active against Western corn rootworm larvae.

Authors:  Frederick S Walters; Cheryl M Stacy; Mi Kyong Lee; Narendra Palekar; Jeng S Chen
Journal:  Appl Environ Microbiol       Date:  2007-11-16       Impact factor: 4.792

10.  Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase.

Authors:  S Pontremoli; E Melloni; M Michetti; O Sacco; B Sparatore; F Salamino; G Damiani; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.